These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15284360)

  • 21. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C; Frei D; Perkins AC
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
    Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythropoietin prevents oxidative stress and lipid peroxidation process in human umbilical vein endothelial cells induced by tumor necrosis factor alpha].
    Szczepański M; Kamianowska M; Wnuczko K; Skrzydlewska E; Wołczyński S
    Pol Merkur Lekarski; 2006 Dec; 21(126):534-9. PubMed ID: 17405292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
    Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
    Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malnutrition, inflammation, atherosclerosis in hemodialysis patients.
    Jeznach-Steinhagen A; Słotwiński R; Szczygieł B
    Rocz Panstw Zakl Hig; 2007; 58(1):83-8. PubMed ID: 17711095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis.
    Yu TM; Chen YH; Hsu JY; Sun CS; Chuang YW; Chen CH; Wu MJ; Cheng CH; Shu KH
    Nephrol Dial Transplant; 2009 Jun; 24(6):1946-51. PubMed ID: 19164324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
    Chiang CK; Yang SY; Peng YS; Hsu SP; Pai MF; Huang JW; Hung KY; Wu KD
    Am J Nephrol; 2009; 29(5):392-7. PubMed ID: 18974640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients].
    de Mutsert R; Krediet RT
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2023-7. PubMed ID: 17058458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells.
    Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Di Silvestre S; Amoroso L; Di Tomo P; Capani F; Consoli A; Bonomini M
    J Cell Physiol; 2007 Dec; 213(3):699-709. PubMed ID: 17516566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
    Himmelfarb J
    Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.